Literature DB >> 27327996

Unchaining NK cell-mediated anticancer immunosurveillance.

Laurence Zitvogel1, Guido Kroemer2.   

Abstract

Mesh:

Year:  2016        PMID: 27327996     DOI: 10.1038/ni.3471

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  11 in total

1.  A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma.

Authors:  Don M Benson; Adam D Cohen; Sundar Jagannath; Nikhil C Munshi; Gary Spitzer; Craig C Hofmeister; Yvonne A Efebera; Pascale Andre; Robert Zerbib; Michael A Caligiuri
Journal:  Clin Cancer Res       Date:  2015-05-21       Impact factor: 12.531

2.  Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy.

Authors:  Stephen J Blake; Kimberley Stannard; Jing Liu; Stacey Allen; Michelle C R Yong; Deepak Mittal; Amelia Roman Aguilera; John J Miles; Viviana P Lutzky; Lucas Ferrari de Andrade; Ludovic Martinet; Marco Colonna; Kazuyoshi Takeda; Florian Kühnel; Engin Gurlevik; Günter Bernhardt; Michele W L Teng; Mark J Smyth
Journal:  Cancer Discov       Date:  2016-01-19       Impact factor: 39.397

Review 3.  The Basis of Oncoimmunology.

Authors:  A Karolina Palucka; Lisa M Coussens
Journal:  Cell       Date:  2016-03-10       Impact factor: 41.582

Review 4.  Natural innate and adaptive immunity to cancer.

Authors:  Matthew D Vesely; Michael H Kershaw; Robert D Schreiber; Mark J Smyth
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

5.  CIS associates with the interleukin-2 receptor beta chain and inhibits interleukin-2-dependent signaling.

Authors:  M J Aman; T S Migone; A Sasaki; D P Ascherman; M h Zhu; E Soldaini; K Imada; A Miyajima; A Yoshimura; W J Leonard
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

6.  The signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation.

Authors:  Xuexian O Yang; Huiyuan Zhang; Byung-Seok Kim; Xiaoyin Niu; Juan Peng; Yuhong Chen; Romica Kerketta; Young-Hee Lee; Seon Hee Chang; David B Corry; Demin Wang; Stephanie S Watowich; Chen Dong
Journal:  Nat Immunol       Date:  2013-06-02       Impact factor: 25.606

Review 7.  Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents.

Authors:  Lorenzo Galluzzi; Aitziber Buqué; Oliver Kepp; Laurence Zitvogel; Guido Kroemer
Journal:  Cancer Cell       Date:  2015-12-14       Impact factor: 31.743

8.  TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells.

Authors:  Laurie Menger; Agnes Gouble; Maria A V Marzolini; Annette Pachnio; Katharina Bergerhoff; Jake Y Henry; Julianne Smith; Martin Pule; Paul Moss; Stanley R Riddell; Sergio A Quezada; Karl S Peggs
Journal:  Blood       Date:  2015-10-27       Impact factor: 22.113

9.  Cancer immunoediting by the innate immune system in the absence of adaptive immunity.

Authors:  Timothy O'Sullivan; Robert Saddawi-Konefka; William Vermi; Catherine M Koebel; Cora Arthur; J Michael White; Ravi Uppaluri; Daniel M Andrews; Shin Foong Ngiow; Michele W L Teng; Mark J Smyth; Robert D Schreiber; Jack D Bui
Journal:  J Exp Med       Date:  2012-08-27       Impact factor: 14.307

10.  Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance.

Authors:  Douglas C Palmer; Geoffrey C Guittard; Zulmarie Franco; Joseph G Crompton; Robert L Eil; Shashank J Patel; Yun Ji; Nicholas Van Panhuys; Christopher A Klebanoff; Madhusudhanan Sukumar; David Clever; Anna Chichura; Rahul Roychoudhuri; Rajat Varma; Ena Wang; Luca Gattinoni; Francesco M Marincola; Lakshmi Balagopalan; Lawrence E Samelson; Nicholas P Restifo
Journal:  J Exp Med       Date:  2015-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.